Reference
  1. M Aldehaim , R Mahmood , F Hussain , A Memon , A Al-Hebshi et al. Anaplastic Thyroid Cancer: A Retrospective Analysis of 120 Cases. Gulf J Oncolog. 2014;1(15):32-37.
  2. Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 2005;103(7):1330-1335.
  3. Kim TY, Kim KW, Jung TS, et al. Prognostic factors for Korean patients with anaplastic thyroid carcinoma. HeadNeck. 2007;29(8):765-772.
  4. Akaishi J, Sugino K, Kitagawa W, et al. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid. 2011;21(11):1183-1189.
  5. Bisof V, Rakusic Z, Despot M. Treatment of patients with anaplastic thyroid cancer during the last 20 years :whether any progress has been made? Eur Arch Otorhinolaryngol. 2015;272(7):1553-1567.
  6. Sugitani I, Miyauchi A, Sugino K, et al. Prognostic factorsand treatment outcomes for anaplastic thyroidcarcinoma : ATC Research Consortium of Japan cohort study of 677 patients. World J Surg. 2012;36(6):1247-1254.
  7. Ito K, Hanamura T, Murayama K, et al. Multimodality therapeutic outcomes in anaplastic thyroid carcinoma : improved survival in subgroups of patients with localized primary tumors. Head Neck. 2012;34(2):230-237.
  8. Haymart MR, Banerjee M, Yin H, et al. Marginal treatment benefit in anaplastic thyroid cancer. Cancer. 2013;119(17):3133-3139.
  9. Yoshida A, Sugino K, Sugitani I, et al. Anaplasti thyroid carcinomas incidentally found on postoperative pathological examination. World J Surg. 2014;38(9):2311-2316.
  10. Chen J, Tward JD, Shrieve DC, et al. Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma. Analysis of the surveillance, epidemiology, and end results 1983-2002. Am J Clin Oncol. 2008;31(5):460-464.
  11. Foote RL, Molina JR, Kasperbauer JL, et al. Enhanced survival in locoregionally confined anaplastic thyroid carcinoma : a single-institution experience using aggressive multimodal therapy. Thyroid. 2011;21(1):25-30.
  12. Tomoe Abe, Masaru Suzuki, Kaoruko Shimizu, Naofumi Shinagawa, Satoshi Oizumi, Anaplastic transformation of papillary thyroid carcinoma in multiple lung metastases presenting with a malignant pleural effusion: a case report. Journal of Medical Case Reports. 2014;8:460.
  13. Hyunsung Kim, Yong Wook Park, Young-Ha Oh, Jongmin Sim, Jae Y. Ro. Anaplastic Transformation of Papillary Thyroid Carcinoma Only Seen in Pleural Metastasis: A Case Report with Review of the Literature. Head and Neck Pathol. 2017;11(2):162–167.
  14. Ito Y, Higashiyama T, Hirokawa M, et al. Prognosis of patients with papillary carcinoma showinganaplastic transformation in regional lymph nodes that were curatively resected. Endocr J. 2008;55(6):985-989.
  15. Quiros RM, Ding HG, Gattuso P, et al. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103(11):2261-2268.
  16. Wang HM, Huang YW, Huang JS, et al. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma. Ann Surg Oncol. 2007;14(10):3011-3018.
  17. Elliott DD, Sherman SI, Busaidy NL, et al. Growth factor receptors expression in anaplastic thyroid carcinoma:potential markers for therapeutic stratification. Hum Pathol. 2008:39(1);15-20.
  18. Wiseman SM, Griffith OL, Deen S, et al. Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch Surg. 2007;142(8):717-729.